000 05322nam a22005053u 4500
001 EBL1798300
006 m d
007 cr -n---------
008 141019s2014||||||| s|||||||||||eng|d
020 _a9780124079014
_c161.91 (UA)
035 _a(AU-PeEL)1798300
035 _a(OCoLC)892240074
040 _aAU-PeEL
_beng
_cAU-PeEL
_dAU-PeEL
050 4 _aRG627.6 .D79 D796 2014
082 0 0 _a618.32
090 _aRG627.6 .D79 D796 2014
100 1 _aSchaefer, Christof.
245 1 0 _aDrugs During Pregnancy and Lactation :
_bTreatment Options and Risk Assessment
250 _a3rd ed.
260 _aBurlington :
_bElsevier Science,
_c2014.
300 _a1 online resource (919 p.)
490 0 _aeBooks on Demand
505 0 _aCover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1 - General commentary on drug therapy and drug risks in ­pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility
505 8 _a1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2 - Specific drug therapiesduring pregnancy; 2.1 - Analgesics, non-steroidal anti-­inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone
505 8 _a2.1.4 Analgesic drug combination products and drugs used for osteoarthritis2.1.5 Opioid agonists and antagonists and other centrally acting analgesics; 2.1.6 Non-steroidal anti-inflammatory and antirheumatic drugs; 2.1.7 Migraine therapy; 2.1.8 Muscle relaxants and other analgesics; 2.1.9 Antigout preparations; References; 2.2 - Allergy and hyposensitization therapy; 2.2.1 Antihistamines (H1-blocker); 2.2.2 Hyposensitization therapy; 2.2.3 C1-Esterase inhibitor deficiency; References; 2.3 - Antiasthmatic and cough ­medication; 2.3.1 Selective β2-adrenergic agonists
505 8 _a2.3.2 Inhaled corticosteroids (ICSs)2.3.3 Theophylline; 2.3.4 Leukotriene antagonists; 2.3.5 Mast cell stabilizers (inhibitors); 2.3.6 Anticholinergics; 2.3.7 Omalizumab and roflumilast; 2.3.8 Expectorants and mucolytic agents; 2.3.9 Antitussives; 2.3.10 Non-selective β-adrenergic agonists; References; 2.4 - Nausea and vomiting in pregnancy; 2.4.1 Treatment options; 2.4.2 Complementary treatment options; 2.4.3 Pharmacological treatment options; 2.4.4 Dopamine antagonists; 2.4.5 Pyridoxine (vitamin B6); 2.4.6 Vitamin B1; 2.4.7 Serotonin antagonists; 2.4.8 Glucocorticoids
505 8 _a2.4.9 Other antiemeticsSummary; References; 2.5 - Gastro-intestinal medications, hypolipidemic agents and ­spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents
505 8 _a2.5.15 Appetite suppressants, weight loss medications, and obesity
520 _a Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new
588 _aDescription based upon print version of record.
650 4 _aFetus -- Effect of drugs on -- Handbooks, manuals, etc.
650 4 _aNewborn infants -- Effect of drugs on -- Handbooks, manuals, etc.
650 4 _aObstetrical pharmacology -- Handbooks, manuals, etc.
650 4 _aPregnant women -- Drug use.
650 4 _aPregnant women -- Medical care.
655 0 _aElectronic books.
700 1 _aPeters, Paul W.J.
700 1 _aMiller, Richard K.
776 0 8 _iPrint version:
_aSchaefer, Christof
_tDrugs During Pregnancy and Lactation : Treatment Options and Risk Assessment
_dBurlington : Elsevier Science,c2014
_z9780124080782
856 4 0 _uhttp://uttyler.eblib.com/patron/FullRecord.aspx?p=1798300
_yClick here to view this ebook.
901 _aEBL
942 _cEBOOK
_2lcc
999 _c861441
_d865866